MedTrace Logo

Intensity-Modulated Radiation Therapy in Treating Patients With Localized Prostate Cancer

NCT00392535 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 3216

Last updated 2019-02-27

No results posted yet for this study

Summary

RATIONALE: Specialized radiation therapy that delivers a high dose of radiation directly to the tumor may kill more tumor cells and cause less damage to normal tissue. It is not yet known which schedule of intensity-modulated radiation therapy is more effective in treating patients with prostate cancer.

PURPOSE: This randomized phase III trial is studying the side effects of three schedules of intensity-modulated radiation therapy and compares how well they work in treating patients with localized prostate cancer.

Conditions

Interventions

RADIATION

conventional radiotherapy 74 Gy delivered in 37 fractions

RADIATION

hypofractionated radiation therapy 60 Gy in 20 fractions

RADIATION

hypofractionated radiation therapy 57 Gy in 19 fractions

Sponsors & Collaborators

  • Institute of Cancer Research, United Kingdom

    lead OTHER

Principal Investigators

  • David P. Dearnaley, FRCR · Royal Marsden NHS Foundation Trust

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
120 Years
Sex
MALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-18
Primary Completion
2015-09-08
Completion
2021-06-17

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00392535 on ClinicalTrials.gov